979 results for "Mindfulness"
Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness.
Communications biology – September 19, 2024
Summary
No Summary
Abstract
Disorders of consciousness (DoC) represent a challenging and complex group of neurological conditions characterised by profound disturbances in con...
Meditation for Anxiety: A Holistic Approach to Treatment.
Journal of holistic nursing : official journal of the American Holistic Nurses' Association – December 01, 2024
Summary
No Summary
Abstract
This comprehensive integrated literature review provides evidence-based information on mindfulness meditation as a primary care treatment for anxie...
Evaluating passive physiological data collection during Spravato treatment.
Frontiers in digital health – January 01, 2023
Summary
No Summary
Abstract
Spravato and other drugs with consciousness-altering effects show significant promise for treating various mental health disorders. However, the ef...
Stress-reducing interventions in pregnancy for the prevention of preterm birth: a systematic review and meta-analysis.
Journal of psychosomatic obstetrics and gynaecology – December 01, 2023
Summary
No Summary
Abstract
Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality. Maternal stress during pregnancy is an established risk factor for PT...
Complementary and integrative interventions for PTSD.
European journal of psychotraumatology – January 01, 2023
Summary
No Summary
Abstract
ABSTRACTTo treat the impact of trauma, most current evidence supports the use of trauma-focused psychotherapy as the first line approach. However, ...
Tags
Understanding the Mechanisms of Action and Effects of Drugs of Abuse.
Molecules (Basel, Switzerland) – June 24, 2023
Summary
No Summary
Abstract
Drug abuse and addiction are major public health concerns, with millions of people worldwide affected by the negative consequences of drug use. To ...
Feasibility of Integrating MEditatioN inTO heaRt Disease (the MENTOR Study): A Phase II Randomized Controlled Trial.
The Journal of cardiovascular nursing
Summary
No Summary
Abstract
Comorbid depression and/or anxiety symptoms occur in 25% of patients attending cardiac rehabilitation (CR) programs and are associated with poorer ...
Cessations of consciousness in meditation: Advancing a scientific understanding of nirodha samāpatti.
Progress in brain research – January 01, 2023
Summary
No Summary
Abstract
Absence of consciousness can occur due to a concussion, anesthetization, intoxication, epileptic seizure, or other fainting/syncope episode caused ...
Consciousness and the fallacy of misplaced objectivity.
Neuroscience of consciousness – January 01, 2021
Summary
No Summary
Abstract
Objective correlates-behavioral, functional, and neural-provide essential tools for the scientific study of consciousness. But reliance on these co...
Nondual Awareness and Minimal Phenomenal Experience.
Frontiers in psychology – January 01, 2020
Summary
No Summary
Abstract
Minimal phenomenal experiences (MPEs) have recently gained attention in the fields of neuroscience and philosophy of mind. They can be thought of a...
Teacher plants - Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives.
Journal of ethnopharmacology – March 25, 2022
Summary
No Summary
Abstract
Indigenous groups of the Amazon have developed intricate methods for the application of psychoactives, among which particularly the dieta or diet m...
Neural Pattern of Chanting-Driven Intuitive Inquiry Meditation in Expert Chan Practitioners.
Behavioral sciences (Basel, Switzerland) – September 05, 2025
Summary
Expert Chan/Zen meditators exhibit distinct brain patterns. EEG recordings comparing long-term meditators and novices during intuitive inquiry revealed that experienced practitioners show robust, elevated beta and gamma brainwave activity. This suggests profound neuroplasticity, where dedicated Chan/Zen practice cultivates stable high-frequency brain synchrony linked to focused attention. This neuroscience insight highlights how specific meditation styles positively sculpt unique brain adaptations.
Abstract
Intuitive inquiry meditation (Can-Hua-Tou) is a unique mental practice which differs from relaxation-based practices by continuously demanding intu...
A Perspective on Psychedelics as Treatments for Addictions.
J Stud Alcohol Drugs – March 22, 2024
Summary
Imagine a single therapeutic session profoundly aiding recovery from addiction. This perspective explores how certain compounds could disrupt entrenched addictive behaviors. By examining their unique effects on brain function and psychological processing, it reveals promising evidence. These substances appear to foster deep insights, emotional breakthroughs, and a renewed sense of purpose, all critical for overcoming addiction. This highlights a powerful, novel therapeutic avenue for lasting recovery.
Abstract
A Perspective on Psychedelics as Treatments for Addictions.
A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness
Advanced Science – November 20, 2025
Summary
Simulating psychedelic drugs like LSD and psilocybin significantly shifted brain activity in patients with disorders of consciousness closer to a complex, flexible state. Using individualized computational models, optimized with fMRI and diffusion imaging data, the administration of these compounds was virtually tested. Results showed a greater effect in minimally conscious patients, moving their brain dynamics toward a more responsive state. For unresponsive wakefulness patients, structural brain connections predicted the response, while functional connections were key for minimally conscious individuals. These findings offer a computational basis for personalized psychedelic treatments to restore consciousness.
Abstract
Abstract Disorders of consciousness (DoC), including unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), have limited trea...
Treatment of alcoholism using psychedelic drugs: a review of the program of research.
Journal of psychoactive drugs – January 01, 1998
Summary
Psychedelic drugs were once explored as a novel approach to treating alcoholism. Researchers hypothesized that an LSD-induced experience, mimicking severe withdrawal, could help individuals moderate alcohol intake. Early studies, using various designs, showed intriguing potential. Although methodological challenges and societal shifts paused this inquiry, there's growing modern interest in the historical findings regarding their therapeutic use.
Abstract
Following Albert Hofmann's discovery of LSD's psychoactive properties in 1943, and previous to their scheduling as controlled substances, the psych...
Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement
Journal of the History of the Behavioral Sciences – February 01, 2021
Summary
Timothy Leary's early psilocybin and LSD research, foundational to the psychedelic movement, was surprisingly bankrolled by wealthy patrons and classic philanthropy. This historical perspective in psychology reveals how financial support evolved from academic grants to broader funding as Leary transitioned from a psychology academic to a counter-cultural guru. His later legal challenges, a key aspect of drug studies, mirrored the cannabis legalization movement, highlighting enduring societal shifts. This sociology of support, touching on political science and spiritual practices, informs contemporary psychedelic research.
Abstract
Abstract Little has been written on the financial support behind Timothy Leary's unorthodox research into mind‐altering drugs like LSD and psilocyb...
Psychedelic crossings: American mental health and LSD in the 1970s.
Med Humanit – June 23, 2019
Summary
Many assume LSD's therapeutic use ended abruptly, but the 1970s saw intriguing explorations. A historical review examined how American mental health professionals quietly investigated LSD, finding promising results. Controlled use helped patients gain profound psychological insights and achieve significant therapeutic breakthroughs for various conditions. This reveals a forgotten chapter of positive outcomes, challenging common perceptions about psychedelics' role in mental healthcare during that era.
Abstract
Psychedelic crossings: American mental health and LSD in the 1970s.
Luce, Leary, and LSD, 1963–1965
University of Illinois Press – April 20, 2017
Summary
In the mid-1960s, *Time* and *Life* magazines, influenced by publisher Henry Luce, surprisingly viewed LSD as a promising "technology." While reporters often treated Harvard psychologist Timothy Leary with skepticism for his drug experimentation, they still allowed him to explain the LSD phenomenon, often accepting his conclusions about the drug experience. Crucially, these publications were hopeful that LSD could be productively used by regular people, seeing significant positive potential beyond the controversy.
Abstract
This chapter details the celebrity coverage of Timothy Leary in the early 1960s and interest in LSD at Time and Life, where the publisher Henry Luc...
The spiritual core of the hard problem: consciousness as foundational, not emergent.
Frontiers in psychology – January 01, 2025
Summary
What if consciousness isn't born from the brain, but is reality's very foundation? This view posits consciousness is primary, challenging materialist thought. Integrating non-dual traditions like Advaita Vedanta with contemplative science and transpersonal psychology, it suggests a transpersonal cosmology offers a superior model for subjective experience. Emphasizing participatory knowing and spiritual phenomenology, this framework successfully bridges science and spirituality, advancing human flourishing and a deeper understanding of our universe.
Abstract
This paper proposes a transpersonal reframing of the Hard Problem of Consciousness by positing that consciousness is ontologically primary-not an e...
Proposed Consensus Statement on Defining Psychedelic Drugs.
Psychedelic Med (New Rochelle) – March 13, 2023
Summary
Establishing a clear, shared definition for psychedelic drugs is crucial for advancing research. Experts reviewed current understanding and proposed a consensus definition, emphasizing their unique pharmacological action and profound impact on perception. This precise framework promises to unify scientific discourse, fostering clearer communication and accelerating the development of these promising compounds for therapeutic benefit.
Abstract
Proposed Consensus Statement on Defining Psychedelic Drugs.
Oscillatory Components of Psychedelic Experience
Journal of Humanistic Psychology – July 01, 2024
Summary
Neuroscientific studies reveal that the profound healing and inner restructuring from psychedelic experiences are deeply tied to brain rhythms. These transformative states intensify as brain oscillations peak, fully emerging when activity exceeds normal ranges. Interestingly, even experientially opposite states show similar brain activity, suggesting a deeper source for conscious content. This dynamic interplay offers significant therapeutic potential.
Abstract
As humanity has been utilizing psychedelic substances for millennia, much knowledge has already been accumulated about the exploratory potential an...
Humphry Fortescue Osmond (1917-2004), a radical and conventional psychiatrist: The transcendent years.
Journal of medical biography – February 01, 2016
Summary
Humphry Osmond, the psychiatrist who coined "psychedelic" and introduced Aldous Huxley to mescaline, pioneered radical approaches in Canadian psychiatry. Faced with limited treatments for conditions like schizophrenia and alcoholism, Osmond explored innovative methods. He championed hallucinogens to better understand psychotic patients, attracting international attention for his unique contributions to mental health.
Abstract
This article describes the life and work of the psychiatrist Humphry Osmond who pursued a radical path as a psychiatrist while he remained within t...
Flashback: psychiatric experimentation with LSD in historical perspective.
Canadian journal of psychiatry. Revue canadienne de psychiatrie – June 01, 2005
Summary
Before its counterculture fame, LSD was seriously investigated for psychiatric therapy. Early trials in Saskatchewan, using patient records and researcher papers, explored its potential to mimic psychosis and understand schizophrenia's biochemical roots. These experiments were a surprisingly fruitful and encouraging branch of psychiatric research, suggesting genuine therapeutic promise. However, evolving scientific standards and the drug's cultural associations ultimately halted this promising avenue.
Abstract
In the popular mind, d-lysergic acid diethylamide (LSD) research in psychiatry has long been associated with the CIA-funded experiments conducted b...
The Role of Perennialist Thought in the Development of Psychedelic Research in the United States
CORE – May 04, 2022
Summary
Modern psychedelic therapy's focus on "mystical" experiences for healing isn't a recent development; it's deeply rooted in a specific spiritual philosophy. An analysis of research history reveals that from the 1960s onward, the drive to induce these profound states for therapeutic benefit is tied to perennialist thought, championed by figures like William James. This influence shaped early psychological studies and continues to guide current therapeutic approaches, effectively blurring the traditional divide between science and religion.
Abstract
From the 1960s to the present day, American research into the therapeutic effects of psychedelic drugs has focused on their ability to facilitate “...
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
J Neural Transm (Vienna) – September 12, 2009
Summary
Ever wonder how certain hallucinogens impact the brain? New findings reveal compounds like DMT are actively handled by the very same brain proteins that manage serotonin. Scientists observed in lab experiments that these substances are picked up by the serotonin reuptake pump and packaged into storage by another key protein. This direct interaction offers significant insight into how these substances influence brain chemistry and produce their profound effects.
Abstract
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine tr...
A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.
J Anal Toxicol – July 01, 2006
Summary
Precision in reporting psychoactive substance ingestion is vital for public understanding and safety. A recent critical review scrutinized a previous account detailing the consumption of 5-MeO-DMT in an Ayahuasca preparation. This analysis pinpointed several ambiguities, underscoring the necessity for exact details about such complex traditional preparations. Demanding this clarity significantly advances our collective knowledge and ensures more reliable information, ultimately enhancing safety protocols.
Abstract
A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.
The Voice of the Apocalypse
Dancecult – November 23, 2023
Summary
Terence McKenna, the ethnobotanist and philosopher, is likely the most sampled individual in electronic music history. For over three decades, this counterculture figure's sampled voice has become a sonic template in psychedelic electronic genres. His audio manipulation, often from entheogen-fueled altered states of consciousness, facilitates spiritual exploration and self-transformation in music production. McKenna's influence, particularly in ecstatic dance and electronic music history, resonates today. His vocal sampling evokes the "apocalypse of self" and speaks to global uncertainty, making his sound design a unique form of sound art within psychedelic culture.
Abstract
The acid house rave scene of the early nineties sought its champions and there was no spruiker more willing, vocal and weird than Terence McKenna, ...
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.
Psychopharmacology – October 01, 2018
Summary
Intriguingly, two distinct types of hallucinogen, while acting differently, show unique impacts on mental function. Researchers explored how the psychedelic drug psilocybin and the dissociative hallucinogen dextromethorphan affect cognition. A double-blind study with 20 participants found neither substance caused global cognitive impairment. Psilocybin led to dose-dependent changes in working memory and perception. Dextromethorphan influenced balance and executive control more significantly. Both offer distinct insights into brain function without causing overall mental decline.
Abstract
Classic psychedelics (serotonin 2A receptor agonists) and dissociative hallucinogens (NMDA receptor antagonists), though differing in pharmacology,...
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.
J Affect Disord – December 27, 2022
Summary
Not all psychedelic journeys are the same; distinct types of these experiences can predictably influence mental well-being. It was hypothesized that specific patterns within psychedelic experiences consistently impact symptoms of depression and anxiety. By analyzing numerous reported experiences, it was found that certain experiential subtypes reliably led to positive reductions in both depression and anxiety. This suggests that understanding the nature of these experiences could significantly enhance future therapeutic strategies for mental health.
Abstract
Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.
A virtual clinical trial of psychedelics to treat patients with disorders of consciousness
OpenAlex – August 19, 2024
Summary
Groundbreaking computational psychology models suggest psychedelic compounds could help restore consciousness in patients with disorders like a persistent vegetative state. Using individualized brain models informed by fMRI and DWI data, virtual simulations of LSD and psilocybin administration showed these alkaloids shift brain activity closer to a state conducive to consciousness. This effect was more pronounced in minimally conscious patients. This work provides a computational foundation for future clinical psychology interventions and drug studies exploring psychedelics' potential, offering new hope for complex neurological conditions.
Abstract
Disorders of consciousness (DoC), including the unresponsive wakefulness syndrome (UWS) and the minimally conscious state (MCS), have limited treat...
A complex systems perspective on psychedelic brain action.
Trends Cogn Sci – February 03, 2023
Summary
Psychedelics don't just alter perception; they profoundly reorganize brain activity. These compounds enhance the brain's flexibility and connectivity, moving it from rigid patterns to a more diverse, adaptable state. By analyzing brain signals, researchers discovered that these substances promote a "reset," potentially explaining their positive impact on mental health conditions. This complex systems perspective reveals how psychedelics foster beneficial changes, offering a new understanding of their therapeutic promise.
Abstract
A complex systems perspective on psychedelic brain action.
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing
PsyArXiv – May 24, 2022
Summary
Many report microdosing boosts mood and creativity, but is it the substance or expectation? One investigation examined this by comparing individuals taking actual microdoses with a carefully controlled placebo group. Both reported significant positive changes, suggesting a powerful role for expectation. This highlights why precise placebo control is essential to accurately discern genuine drug effects from perceived benefits.
Abstract
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing
LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory
OpenAlex – May 17, 2021
Summary
Psychedelics like LSD and psilocybin significantly ease the brain's ability to transition between different activity states, promoting more varied dynamics. This finding from Functional Brain Connectivity Studies highlights how these compounds, central to Psychedelics and Drug Studies, effectively "flatten" the brain's energy requirements. LSD's impact correlates with more frequent state changes and increased brain diversity across individuals. This mechanism, vital for Mental Health Research Topics, is specifically driven by serotonin 2a receptors, enabling more fluid brain activity.
Abstract
Abstract Psychedelics like lysergic acid diethylamide (LSD) and psilocybin offer a powerful window into the function of the human brain and mind, b...
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
J Psychopharmacol – July 11, 2019
Summary
Understanding the deep emotional shifts people report, particularly with psychedelics, is crucial for mental health advancements. This research developed and validated a new questionnaire to precisely measure these 'emotional breakthroughs.' Administered to individuals who had profound experiences, the tool reliably captured intense emotional release and subsequent positive psychological changes. The findings confirm this inventory is a robust and valid measure, offering a precise way to assess these transformative experiences and their therapeutic potential.
Abstract
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
Serotonin, psychedelics and psychiatry
World Psychiatry – September 07, 2018
Summary
In Psychiatry, just one or two psychedelic treatment sessions can yield therapeutic effects lasting several months for mood disorders and addiction—an unprecedented outcome. Neuropsychopharmacology reveals Serotonin's complex role, with 5-HT2A neurotransmitter receptor influence on behavior being key to the "psychedelic experience" and heightened context sensitivity. This shift in Medicine and Drug Studies, moving beyond traditional psychoanalysis and simple Serotonin deficiency models, highlights new Psychology avenues exploring how these compounds, often alkaloids, profoundly impact mental health.
Abstract
Serotonin is a key neuromodulator known to be involved in brain development, perception, cognition, and mood. However, unlike as with dopamine for ...
Psychedelics, Personality and Political Perspectives.
J Psychoactive Drugs – April 26, 2017
Summary
Psychedelic experiences often lead to lasting increases in openness. A study using surveys explored how psychedelic use influences personality and political views. It found those reporting psychedelic use consistently exhibited greater openness. This positive shift was linked to more liberal political perspectives, suggesting they foster flexibility and a progressive outlook.
Abstract
Psychedelics, Personality and Political Perspectives.
Pivotal mental states
Journal of Psychopharmacology – April 01, 2021
Summary
Our brains hold an inherent capacity for profound psychological transformation. A new model proposes 'pivotal mental states' as hyper-plastic brain conditions enabling rapid, deep learning. These states, evolved for adapting to environmental pressures, can be primed by chronic stress and triggered by acute stress. Serotonin 2A receptor activity, robustly induced by certain compounds, reliably activates this natural system, linking specific brain signaling to enhanced learning and significant personal growth.
Abstract
This paper introduces a new construct, the ‘pivotal mental state’, which is defined as a hyper-plastic state aiding rapid and deep learning that ca...
Psychiatry & the psychedelic drugs. Past, present & future.
Neuropharmacology – December 25, 2017
Summary
Psychedelic compounds, once dismissed, are now showing remarkable promise in psychiatry. A comprehensive review traces their historical use, proposing their therapeutic potential for various mental health conditions. Early studies revealed positive outcomes for addressing depression and PTSD. Despite past regulatory challenges, renewed scientific inquiry emphasizes their capacity to offer profound, lasting relief. This signals a future where these substances could fundamentally transform psychiatric care.
Abstract
Psychiatry & the psychedelic drugs. Past, present & future.
Psychedelics as Psychiatric Medications
OpenAlex – March 01, 2023
Summary
Psilocybin, a potent hallucinogen, effectively alleviates distress in individuals with cancer-related depression and anxiety. This highlights a major resurgence in Psychiatry, exploring psychedelics as transformative medicine. Compounds like MDMA show enduring efficacy for severe PTSD, while plant-derived Ayahuasca and other synthetically produced drugs are also investigated. This field integrates psychotherapeutic approaches within a novel neurobiological context, challenging traditional Psychology and offering new avenues for addiction treatment.
Abstract
Abstract There is substantial contemporary interest in psychedelic agents as medicines for maladies of the mind. This follows research in the 1950s...
Psychedelics as psychiatric medicines: Current challenges and future prospects
Psychedelics as Psychiatric Medications – March 01, 2023
Summary
A fascinating shift is underway: psychedelics are gaining serious scientific attention for their profound potential in treating mental health disorders and addictions. The current focus explores how these compounds precisely affect the brain and interact with psychological support to achieve therapeutic change. Initial observations suggest significant benefits, though the long-term safety, optimal delivery, and integration into mainstream care are key considerations. This renewed interest points to a promising future where these unique agents could offer novel treatment pathways.
Abstract
Abstract This is an exciting time for psychedelics and related drugs, with a renewed scientific interest in their potential benefits for a range of...
Intensive training induces longitudinal changes in meditation state-related EEG oscillatory activity.
Frontiers in human neuroscience – January 01, 2012
Summary
Intensive meditation training demonstrably reconfigures brain activity, offering insights into how sustained attention improves. Researchers investigated how months of focused meditation training impact brainwave patterns. Using EEG, they found that participants showed replicable reductions in beta-band power during meditation. Crucially, their individual alpha frequency also decreased, directly correlating with the amount of training. These positive results reveal specific brain changes linked to meditation, enhancing our understanding of its cognitive benefits.
Abstract
The capacity to focus one's attention for an extended period of time can be increased through training in contemplative practices. However, the cog...
Enhanced response inhibition during intensive meditation training predicts improvements in self-reported adaptive socioemotional functioning.
Emotion (Washington, D.C.) – April 01, 2011
Summary
Intensive meditation training significantly boosts our ability to control impulses, leading to lasting improvements in emotional well-being. Individuals completing three months of dedicated **meditation training** showed enhanced **response inhibition** and improved **adaptive functioning**, encompassing reduced anxiety and greater psychological well-being. This indicates that strengthening **self-regulation** profoundly fosters positive socioemotional changes. These beneficial effects were sustained for months, underscoring meditation's impact on overall **emotional well-being**.
Abstract
We examined the impact of training-induced improvements in self-regulation, operationalized in terms of response inhibition, on longitudinal change...
Do Drugs Have Religious Import? A 40-Year Retrospective
Journal of Humanistic Psychology – April 01, 2004
Summary
A leading scholar's four-decade reflection illuminates how psychedelic experiences have profoundly shaped religious traditions, from ancient Vedic and Eleusinian mysteries to the contemporary Native American Church. Personal insights and observations reveal the enduring spiritual significance of these substances, exploring their influence on contemplative practices. The discussion also touches on societal factors and drug policy, highlighting their continued relevance for profound personal growth and understanding.
Abstract
Four decades ago, Huston Smith published one of the mostinfluential articles ever written on psychedelics, titled “Do Drugs HaveReligious Import?” ...
Serotonin 5-HT<sub>2C</sub> Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.
ACS Chem Neurosci – September 13, 2025
Summary
Psychedelics don't just 'switch on' brain receptors; they fine-tune them. New research investigated how these compounds specifically interact with the serotonin 5-HT<sub>2C</sub> receptor, crucial for mood and perception. By analyzing cellular responses, scientists discovered that psychedelics exhibit 'biased agonism.' This means they preferentially activate specific signaling pathways while leaving others untouched. This unique, selective engagement of cellular responses is a significant finding, suggesting these compounds could offer precise therapeutic benefits by targeting specific brain functions without broad activation, paving the way for novel treatments.
Abstract
Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.
Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.
Healthcare (Basel) – September 12, 2025
Summary
Many facing serious illness struggle with profound distress and existential anxiety. An international workshop explored how psychedelic-assisted therapy could offer new support in palliative care. Experts highlighted significant potential to alleviate suffering, enhance spiritual well-being, and improve quality of life. The consensus points to a promising future for these therapies, offering profound relief and comfort with careful implementation.
Abstract
Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop.
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
PLoS ONE – February 18, 2015
Summary
A powerful hallucinogen, Ayahuasca, significantly reduces activity in the brain's default mode network (DMN), a key area for mind-wandering and consciousness. Using functional magnetic resonance imaging (resting state fMRI) on ten experienced subjects, neuroscience revealed decreased activity in regions like the Posterior Cingulate and Precuneus. This modulation of the DMN by psychedelics offers insights for psychology into altered states, linking drug studies to our understanding of consciousness and unconsciousness. This informs neurotransmitter receptor influence on behavior, relevant to tryptophan and brain disorders.
Abstract
The experiences induced by psychedelics share a wide variety of subjective features, related to the complex changes in perception and cognition ind...
Effectiveness of Psilocybin on Depression: A Qualitative Study
Electronic Journal of General Medicine – April 27, 2021
Summary
Psilocybin shows powerful potential in clinical psychology for anxiety and mood disorders. A qualitative research effort involving ten participants revealed profound shifts. Individuals reported enhanced senses, feeling "connected with the universe," and significant mood stabilization. They also experienced increased optimism, emotional control, and healthier emotional connections, suggesting a beneficial impact on mental well-being. This work, relevant to Psychiatry and Psychedelics and Drug Studies, highlights how psilocybin, an alkaloid, may foster new neural perspectives, offering a promising avenue for psychotherapist-guided Complementary and Alternative Medicine.
Abstract
Introduction: Psilocybin mushroom use is well documented in spiritual and religious ceremonies globally. This drug is now the most popular in Europ...
Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD—A retrospective case study
OpenAlex – March 10, 2023
Summary
A compelling case suggests psilocybin, a chemical synthesis alkaloid, could help individuals with severe anxiety and depression understand ordinary states like hopefulness. One individual, suffering early trauma and chronic anxiety and depression since childhood, found traditional psychotherapy and psychiatry unhelpful. Through intensive, self-directed psilocybin use from age 19, he reported achieving a foundational feeling of peace by age 30, despite ongoing societal trauma. This clinical psychology insight suggests psychedelics and drug studies may offer new avenues for treating treatment-resistant depression, influencing neurotransmitter receptor behavior.
Abstract
In medicine, psychedelics were initially considered as a tool for clinicians to understand psychotic states. Based on the presented case data, a re...
PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS
Journal of Neurology Neurosurgery & Psychiatry – August 06, 2013
Summary
A single high-dose of Psilocybin can induce profound, personality-changing spiritual experiences. This highlights a paradox in Psychology: how can such Psychedelics, explored in Drug Studies and linked to Mysticism, be both therapeutically useful in Psychoanalysis and resemble psychosis? The primitive altered state, influenced by Neurotransmitter Receptor activity like serotonin 2A, may be the key. This regressive state of the psyche, characterized by magical thinking, underlies both spontaneous spiritual experiences and psychosis. Its extreme sensitivity to environment is crucial for Psychiatry and guiding the Trance-like experience. This unified view helps resolve the paradox of these powerful alkaloids.
Abstract
After completing an undergraduate degree in Psychology in 2003, Robin studied psychoanalysis at Masters level, receiving his MA in 2004. In 2005, R...
Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
Psychological Medicine – November 04, 2020
Summary
Psychedelics like psilocybin and ayahuasca, potent hallucinogens, demonstrate substantial mental health benefits. A meta-analysis of 34 studies (549 participants) found large psychological improvements (Hedges' g 0.84-1.08) versus placebo in randomized controlled trials. These effects, potentially linked to neurotransmitter receptor influence on behavior, spanned psychiatry and clinical psychology, with moderation for clinical samples. No post-acute adverse effect was observed, advancing interest in these chemical synthesis and alkaloids for Psychedelics and Drug Studies.
Abstract
Abstract Background Scientific interest in the therapeutic effects of classical psychedelics has increased in the past two decades. The psychologic...
Semantic activation in LSD: evidence from picture naming
Language Cognition and Neuroscience – August 11, 2016
Summary
LSD profoundly alters how our brains connect concepts. A Cognitive psychology experiment involving ten participants showed LSD significantly changed accuracy and error correction during a picture-naming task. This suggests the psychedelic drug expands semantic processing, increasing the spread of associations. Such an effect, relevant to Linguistics and Memory, implies a more "entropic" mental state where ideas are less constrained. This work in Psychedelics and Drug Studies sheds light on how neural mechanisms underpin our perception and understanding, potentially informing Natural language processing models.
Abstract
Lysergic acid diethylamide (LSD) is a classic psychedelic drug that alters cognition in a characteristic way. It has been suggested that psychedeli...
Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder
OpenAlex – July 14, 2022
Summary
Psilocybin, a potent hallucinogen, may reduce obsessive-compulsive behaviors without its mind-altering effects. In male ICR mice, Psilocybin (4.4 mg/kg) significantly reduced marble-burying. Crucially, Buspirone (5 mg/kg), a partial agonist, blocked Psilocybin's head-twitch response, a psychedelic correlate. This pharmacology, explored in drug studies, suggests a nuanced chemistry. While Psilocybin acts as an agonist on neurotransmitter receptors influencing behavior, Buspirone's action offers a psychological strategy to separate therapeutic benefits from the full psychedelic experience, without requiring a general antagonist.
Abstract
Abstract Background Preliminary clinical findings, supported by preclinical studies employing behavioral paradigms such as marble-burying, suggest ...
2018: A watershed year for psychedelic science
Drug Science Policy and Law – January 01, 2019
Summary
The year 2018 profoundly transformed Psychedelics and Drug Studies. A key acknowledgement came when the Food and Drug Administration designated psilocybin-assisted psychotherapy a "breakthrough therapy" for depression. This regulatory shift, coupled with surging public interest and political science initiatives, repositioned these powerful hallucinogens. The momentum ignited diverse academic research themes, spanning psychology, social science, and even environmental ethics, solidifying the field's long-term outlook beyond just chemical synthesis and alkaloids.
Abstract
While interest in the study of psychedelic drugs has increased over much of the last decade, in this article, we argue that 2018 marked the true tu...
From Mushrooms to Myolysis
The Journal of Nervous and Mental Disease – July 29, 2022
Summary
No Summary
Abstract
Abstract The involvement of certain recreational drugs, namely, hallucinogens, in the development of hyperactive syndromes is well known, but not w...
Back to the Future — The Therapeutic Potential of Psychedelic Drugs
New England Journal of Medicine – April 14, 2021
Summary
Mescaline, described by Aldous Huxley as "extraordinary," sparked immense interest in hallucinogens. Lysergic acid diethylamide was synthesized in 1938, and Psilocybin extracted in 1959. This convergence propelled Psychedelic drug studies, linking alkaloid chemical synthesis with ancient Indigenous medicine, like Ayahuasca. Psychiatry and Psychology now explore their potential as medicine. Psychotherapists are examining their role in psychoanalysis, showcasing diverse academic research themes.
Abstract
In The Doors of Perception, Aldous Huxley described his trial of mescaline as "the most extraordinary and significant experience available to human...
Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative
Anthropology of Consciousness – August 22, 2022
Summary
Psychedelic medicines, long central to Indigenous and counterculture wisdoms, are now driving multimillion-dollar IPOs in Medicine and Psychiatry. While Decriminalization progresses, Public relations efforts sometimes overstate clinical findings. Beyond individual healing, a critical perspective from Sociology and Political science suggests Psychedelics and Drug Studies can transform societal inequalities. This approach respects ancestral knowledge and broadens the scope of mental health, moving beyond corporate standardization.
Abstract
Psychedelic or ecodelic medicines (e.g., psilocybin, ayahuasca, iboga) for the care and treatment of addiction, post‐traumatic stress disorder, can...
The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review
Brain and Neurological Disorders – June 21, 2022
Summary
The critical lack of objective neuroimaging documentation challenges widespread social media claims about psychedelics like Psilocybin offering mental CLARITY. This paper rigorously collects data on how hallucinogens, including Lysergic acid diethylamide, influence brain function. Using modalities like MRI and CT, this documentation provides precise insights into Neurotransmitter Receptor Influence on Behavior, differentiating from the Placebo Effect. Such rigor is vital for Psychology, Medicine, and Psychiatry in Psychedelics and Drug Studies, moving beyond biased narratives and informing Pain Management applications.
Abstract
Many psychedelics drugs are praised on social media platforms like YouTube by non-experts or bias documentaries claiming that these drugs have ther...
Classification of illegal and harmful drugs
BMJ – August 03, 2006
Summary
The House of Commons Select committee reveals the UK's drug control classification system is "not fit for purpose," causing considerable confusion. Government policy lacks evidence-based decision-making, with "harm" undefined, leading to inconsistent law and medicine applications. For instance, ecstasy, used by 6.8% of 16-59 year olds in England and Wales, remains Class A despite recommendations. The Advisory committee's complacency impacts political science and drug use policy. Critically, no evidence suggests classification deters drug use, and addiction research funding is woefully inadequate.
Abstract
This week the House of Commons Select Committee on Science and Technology published the report of its inquiry on the classification of illegal drug...
A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens
NeuroQuantology – June 01, 2012
Summary
Hallucinogens like psilocybin and mescaline profoundly alter consciousness, inducing euphoriant states or challenging perceptions. Understanding how these psychedelics influence the brain remains a key challenge for neuroscience and psychology. While neurotransmitter receptor influence on behavior, including systems like Nicotinic Acetylcholine Receptors, offers partial explanations, cognitive psychology and psychoanalysis suggest deeper mechanisms. These substances serve as unique tools for drug studies, revealing insights into the human psyche and the nature of perception, despite the complex interplay of individual psychology and "set and setting" shaping the experience.
Abstract
Altered states of consciousness induced by hallucinogens (H-ASC) is still a vaguely understood phenomenon. Taken the diverse psychological effects ...
Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?
Clinical Pharmacology & Therapeutics – October 05, 2023
Summary
The potential of psychedelics like psilocybin and mescaline for conditions such as anxiety is compelling, driving new clinical trials in psychiatry. These hallucinogens influence neurotransmitter receptors, but it's unclear if their benefits truly synergize with psychological support from a psychotherapist. Rigorous 2x2 factorial clinical trials are crucial. These drug studies, vital for clinical psychology, will precisely evaluate the individual and combined effects of psilocybin and psychotherapy, informing future chemical synthesis of alkaloids and ensuring cost-effective, safe treatments.
Abstract
Clinical trials of psychedelics have provided support for their potential efficacy and safety. Although most combined a psychedelic with psychologi...